GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kazia Therapeutics Ltd ADR KZIA · USD

Health Care · US listing · 🇺🇸 United States

Compare

7.41

+3.20%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Kazia Therapeutics Ltd ADR

Our reporting

Next results

2 Mar 2027

Due on 2 Mar 2027. Analysts expect earnings of -0.07 a share on revenue of $2.0m.

Past results

Reported against what analysts expected

4 Sept 202616 Mar 20267 Nov 202519 Nov 202416 Sept 202427 Nov 2023
Earnings per share-0.33-0.58-0.43-20.81-0.30-10.02
Forecast-0.61-0.01-0.01-15.00-3.00-1.66
Revenue$150,394$216,903$10,486$1.7m$100,000$664
Forecast$488,858—$10,451$100,000$100,000—

Key events

  1. 17 Apr 20255-to-1 reverse split
  2. 28 Oct 202410-to-1 reverse split
  3. 14 Jul 20174-to-1 reverse split
  4. 3 Jan 20125-to-1 reverse split
  5. 6 Jan 1999Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.